Jones Ryan Alexander has filed 6 insider transactions across 1 company since April 2024.
Most recent transaction: a grant/award of 12000 shares of Kyverna Therapeutics, Inc. ($KYTX) on April 11, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 11, 2025 | Kyverna Therapeutics, Inc. | $KYTX | Jones Ryan Alexander | Chief Financial Officer | A | Common Stock | 12000 | $0.00 | 55,950.0000 | 43,214,918 | 27.30% | 0.03% |
| April 11, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Jones Ryan Alexander | Chief Financial Officer | A | Stock Option (right to buy) | 74000 | $0.00 | 74,000.0000 | 0 | 9999.99% | 0.00% |
| May 28, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Jones Ryan Alexander | Chief Financial Officer | M | Common Stock | 10870 | $0.73 | 36,804.0000 | 0 | 41.91% | 0.00% |
| May 28, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Jones Ryan Alexander | Chief Financial Officer | M | Common Stock | 7146 | $0.73 | 43,950.0000 | 0 | 19.42% | 0.00% |
| May 28, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Jones Ryan Alexander | Chief Financial Officer | M | Stock Option (Right to Buy) | 10870 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 28, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Jones Ryan Alexander | Chief Financial Officer | M | Stock Option (Right to Buy) | 7146 | $0.00 | 2,192.0000 | 0 | 76.53% | 0.00% |